Da Vinci X is coming
Intuitive is planning to launch an upgrade to the Si, making it a new product, da Vinci X, fitting between the Si and the Xi series: 
"Over the next several quarters, we plan to launch a new technology upgrade to Si, named da Vinci X that enables a compelling entry point to our advanced technologies. da Vinci Xi will remain our flagship and we will provide customers with logical upgrade paths for more affordable entry-level systems like Si and X to Si and Sp.
"Over the next several quarters, we plan to launch a new technology upgrade to Si, named da Vinci X that enables a compelling entry point to our advanced technologies. da Vinci Xi will remain our flagship and we will provide customers with logical upgrade paths for more affordable entry-level systems like Si and X to Si and Sp.
It really combines our latest instrument accessory, robotic, and 
computing and imaging technology with an Si patients cart chassis. This 
brings to market advanced upgrade package for Si technology that’s lost 
between the Si and the Xi in terms of its breadth of clinical reach. And
 it creates an attractive entry point for either an upgrade or a new 
install.
We have submitted our documents for CE Mark review for X
 and anticipate it will be available in Europe in the second quarter, 
with clearances in other regions following over time. We’ll provide you 
with additional information on X as it launches."
The TM for da Vinci X was submitted last Autumn.In the meanwhile, the clinical assessment of the Sp platform takes a little longer than expected:
"Our Sp program continues to progress in its clinical trial work and new 
site initiation. Cases at our active trial site in Asia have included 
transoral, urologic and colorectal surgery. We’re also on track in 
initiating our U.S. IDE sites to gather clinical data in transoral 
surgery. In reviewing feedback from surgeons in Asia and the latest 
standards for human factors validations, we have elected to pull forward
 a software release for Sp ahead of our urology 510(k)." 
Source: Gary Guthart via Seeking Alpha



Comments